Stock Watchlist Weekly (Delivered Sundays 1PM ET)

Share this post

User's avatar
Stock Watchlist Weekly (Delivered Sundays 1PM ET)
📝 3 new picks (Stock Watchlist Weekly 06/11/23)

📝 3 new picks (Stock Watchlist Weekly 06/11/23)

Sunday New Picks (PAID Version)

Jun 11, 2023
∙ Paid

Share this post

User's avatar
Stock Watchlist Weekly (Delivered Sundays 1PM ET)
📝 3 new picks (Stock Watchlist Weekly 06/11/23)
Share

Stock Watchlist Weekly
Posted Sunday, June 11th, 2023; 3PM ET
NOT financial advice. Info for Education/Research/Entertainment purposes only.

Scroll down for this week’s selections.


• PDF: 7 Risk Management Strategies: Top Traders Share Their Best Tips


Share

Examples of recent selections (check the archives for all past picks):
• 2/12/2023: SMCI +192.52% gain!
• 4/23/2023: BLDR +30.15% gain!
• 5/7/2023: ACLS +43.60% gain!


📝 06/11/23 Stock Watchlist Weekly New Algorithm-Generated Selections:

Our proprietary algorithm has analyzed thousands of stocks for both technical and fundamental positive indicators and returned 3 symbols as the best of the week for high-probability, index-beating gain potential, for both short term trader and long-term investor watchlists (with a focus on no-dividend or low-dividend growth-focused stocks).

As always, the algorithm is limited to assessing substantial public companies: NYSE or NASDAQ listed; highly liquid; optionable; share price under $500, either no dividends or dividend yield under 1%.

NOT financial advice. Info for Education/Research/Entertainment purposes only.

1) LGND - Ligand Pharmaceuticals Inc

Sector/Industry: Health Care / Pharmaceuticals

Market Cap: $1.27B

Company Description: Biopharmaceutical company that discovers, develops and markets innovative drugs that address critical unmet medical needs using its patented drug discovery technologies.

Keep reading with a 7-day free trial

Subscribe to Stock Watchlist Weekly (Delivered Sundays 1PM ET) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 StockWatchlistWeekly
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share